Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2025-12-24 @ 2:41 PM
NCT ID:
NCT00541359
Brief Title:
Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
Official Title:
A Phase I Trial of PS-341 in Combination With Topotecan in Advanced Solid Tumor Malignancies
Study:
NCT00541359
Protocol Section:
NCT00541359